ZIMMER BIOMET HOLDINGS, INC. Other Nonoperating Income (Expense)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Nonoperating Income (Expense) of $1.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $1.90M, a 51.28% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$3.00M, a 203.45% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $15.40M.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $3.30M, a 35.29% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for fiscal 2025 was $25.50M.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for fiscal 2024 was -$31.10M.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for fiscal 2023 was -$9.30M.
- ZIMMER BIOMET HOLDINGS, INC. other nonoperating income (expense) for fiscal 2022 was -$128.00M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.90M 10-Q · filed 2026-08-05 | -$1.10M 10-Q · filed 2026-08-05 | $14.30M derived: sum of 3 quarters · filed 2026-08-05 | $17.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$3.00M 10-Q · filed 2026-05-01 | $12.40M derived: sum of 2 quarters · filed 2026-05-01 | $15.70M derived: sum of 3 quarters · filed 2026-05-01 | $19.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $18.70M derived: sum of 2 quarters · filed 2026-02-20 | $22.60M derived: sum of 3 quarters · filed 2026-08-05 | $25.50M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $3.30M 10-Q · filed 2025-11-05 | $7.20M derived: sum of 2 quarters · filed 2026-08-05 | $10.10M 10-Q · filed 2025-11-05 | -$28.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $3.90M 10-Q · filed 2026-08-05 | $6.90M 10-Q · filed 2026-08-05 | -$31.30M derived: sum of 3 quarters · filed 2026-08-05 | -$26.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-01 | -$35.20M derived: sum of 2 quarters · filed 2026-05-01 | -$30.10M derived: sum of 3 quarters · filed 2026-05-01 | -$28.10M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | -$38.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$33.00M derived: sum of 2 quarters · filed 2026-02-20 | -$31.00M derived: sum of 3 quarters · filed 2026-02-20 | -$31.10M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $5.10M 10-Q · filed 2025-11-05 | $7.10M derived: sum of 2 quarters · filed 2025-11-05 | $7.00M 10-Q · filed 2025-11-05 | -$12.60M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-07 | $1.90M 10-Q · filed 2025-08-07 | -$17.70M derived: sum of 3 quarters · filed 2026-02-20 | -$13.90M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | -$100.00K 10-Q · filed 2025-05-05 | -$19.70M derived: sum of 2 quarters · filed 2026-02-20 | -$15.90M derived: sum of 3 quarters · filed 2026-02-20 | -$17.10M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | -$19.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$15.80M derived: sum of 2 quarters · filed 2026-02-20 | -$17.00M derived: sum of 3 quarters · filed 2026-02-20 | -$9.30M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $3.80M 10-Q · filed 2024-10-30 | $2.60M derived: sum of 2 quarters · filed 2024-10-30 | $10.30M 10-Q · filed 2024-10-30 | $6.40M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$1.20M 10-Q · filed 2024-08-07 | $6.50M 10-Q · filed 2024-08-07 | $2.60M derived: sum of 3 quarters · filed 2025-02-25 | -$22.80M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $7.70M 10-Q · filed 2024-05-02 | $3.80M derived: sum of 2 quarters · filed 2025-02-25 | -$21.60M derived: sum of 3 quarters · filed 2025-02-25 | -$64.20M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$29.30M derived: sum of 2 quarters · filed 2025-02-25 | -$71.90M derived: sum of 3 quarters · filed 2025-02-25 | -$128.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$25.40M 10-Q · filed 2023-11-07 | -$68.00M derived: sum of 2 quarters · filed 2023-11-07 | -$124.10M 10-Q · filed 2023-11-07 | -$127.90M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-06-30 | -$42.60M 10-Q · filed 2023-08-01 | -$98.70M 10-Q · filed 2023-08-01 | -$102.50M derived: sum of 3 quarters · filed 2024-08-07 | -$102.20M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-03-31 | -$56.10M 10-Q · filed 2023-05-02 | -$59.90M derived: sum of 2 quarters · filed 2024-08-07 | -$59.60M derived: sum of 3 quarters · filed 2024-08-07 | -$51.60M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2021-12-31 | -$3.80M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | -$3.50M derived: sum of 2 quarters · filed 2024-08-07 | $4.50M derived: sum of 3 quarters · filed 2024-08-07 | $12.20M 8-K · filed 2024-08-07 | $11.80M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-02 | $8.30M derived: sum of 2 quarters · filed 2022-11-02 | $16.00M 10-Q · filed 2022-11-02 | $15.70M 10-Q · filed 2021-11-04 | $22.40M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-06-30 | $8.00M 10-Q · filed 2022-08-02 | $8.10M 10-Q · filed 2021-08-03 | $15.70M 10-Q · filed 2022-08-02 | $15.40M 10-Q · filed 2021-08-03 | $22.10M derived: sum of 3 quarters · filed 2023-02-24 | $32.70M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-03-31 | $7.70M 10-Q · filed 2022-05-05 | $7.30M 10-Q · filed 2021-05-04 | $14.10M derived: sum of 2 quarters · filed 2023-02-24 | $24.70M derived: sum of 3 quarters · filed 2023-02-24 | $28.50M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $17.00M derived: sum of 2 quarters · filed 2023-02-24 | $20.80M derived: sum of 3 quarters · filed 2023-02-24 | $23.80M 10-K · filed 2023-02-24 | $25.40M 10-K · filed 2021-02-22 | |||
| 2020-09-30 | $10.60M 10-Q · filed 2021-11-04 | $14.40M derived: sum of 2 quarters · filed 2021-11-04 | $17.40M 10-Q · filed 2021-11-04 | $22.10M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-06-30 | $3.80M 10-Q · filed 2021-08-03 | $6.80M 10-Q · filed 2021-08-03 | $11.50M derived: sum of 3 quarters · filed 2022-06-22 | $7.10M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-03-31 | $3.00M 10-Q · filed 2021-05-04 | $7.70M derived: sum of 2 quarters · filed 2022-06-22 | $3.30M derived: sum of 3 quarters · filed 2022-06-22 | -$1.40M derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2019-12-31 | $4.70M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $300.00K derived: sum of 2 quarters · filed 2022-06-22 | -$4.40M derived: sum of 3 quarters · filed 2022-06-22 | -$4.90M 8-K · filed 2022-06-22 | -$4.80M 10-K · filed 2020-02-21 | |||
| 2019-09-30 | -$4.40M 10-Q · filed 2020-11-06 | -$9.10M derived: sum of 2 quarters · filed 2020-11-06 | -$9.60M 10-Q · filed 2020-11-06 | -$16.50M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | -$4.70M 10-Q · filed 2020-08-05 | -$5.20M 10-Q · filed 2020-08-05 | -$12.10M derived: sum of 3 quarters · filed 2021-02-22 | -$14.30M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | -$500.00K 10-Q · filed 2020-05-11 | -$7.40M derived: sum of 2 quarters · filed 2021-02-22 | -$9.60M derived: sum of 3 quarters · filed 2021-02-22 | -$12.50M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$9.10M derived: sum of 2 quarters · filed 2021-02-22 | -$12.00M derived: sum of 3 quarters · filed 2021-02-22 | -$15.60M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | -$2.20M 10-Q · filed 2019-11-05 | -$5.10M derived: sum of 2 quarters · filed 2019-11-05 | -$8.70M 10-Q · filed 2019-11-05 | -$13.60M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | -$2.90M 10-Q · filed 2019-08-05 | -$6.50M 10-Q · filed 2019-08-05 | -$11.40M derived: sum of 3 quarters · filed 2020-02-21 | -$13.70M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | -$3.60M 10-Q · filed 2019-05-06 | -$8.50M derived: sum of 2 quarters · filed 2020-02-21 | -$10.80M derived: sum of 3 quarters · filed 2020-02-21 | -$12.50M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | -$4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$7.20M derived: sum of 2 quarters · filed 2020-02-21 | -$8.90M derived: sum of 3 quarters · filed 2020-02-21 | -$9.40M 10-K · filed 2020-02-21 | -$18.30M 10-K · filed 2018-02-27 | |||
| 2017-09-30 | -$2.30M 10-Q · filed 2018-11-01 | -$4.50M 10-Q · filed 2017-11-06 | -$4.00M derived: sum of 2 quarters · filed 2018-11-01 | -$4.50M 10-Q · filed 2018-11-01 | -$11.20M 10-Q · filed 2017-11-06 | -$62.30M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$1.70M 10-Q · filed 2018-08-06 | -$3.90M 10-Q · filed 2017-08-08 | -$2.20M 10-Q · filed 2018-08-06 | -$6.70M 10-Q · filed 2017-08-08 | -$60.00M derived: sum of 3 quarters · filed 2019-02-26 | -$61.10M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | -$500.00K 10-Q · filed 2018-05-08 | -$2.80M 10-Q · filed 2017-05-09 | -$58.30M derived: sum of 2 quarters · filed 2019-02-26 | -$59.40M derived: sum of 3 quarters · filed 2019-02-26 | -$63.20M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$57.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$58.90M derived: sum of 2 quarters · filed 2019-02-26 | -$62.70M derived: sum of 3 quarters · filed 2019-02-26 | -$66.50M 10-K · filed 2019-02-26 | -$71.30M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$1.10M 10-Q · filed 2017-11-06 | -$4.90M derived: sum of 2 quarters · filed 2017-11-06 | -$8.70M 10-Q · filed 2017-11-06 | -$1.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$3.80M 10-Q · filed 2017-08-08 | -$7.60M 10-Q · filed 2017-08-08 | $100.00K derived: sum of 3 quarters · filed 2018-02-27 | $4.40M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$3.80M 10-Q · filed 2017-05-09 | $3.90M derived: sum of 2 quarters · filed 2018-02-27 | $8.20M derived: sum of 3 quarters · filed 2018-02-27 | |||||
| 2015-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $12.00M derived: sum of 2 quarters · filed 2018-02-27 | -$36.90M 10-K · filed 2018-02-27 | |||||
| 2015-09-30 | $4.30M 10-Q · filed 2015-11-09 | -$44.60M 10-Q · filed 2016-11-08 | ||||||
| 2014-12-31 | -$21.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$33.40M derived: sum of 2 quarters · filed 2017-03-01 | -$46.70M 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | -$12.10M 10-Q · filed 2015-11-09 | -$25.40M 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |